You have no items in your shopping cart.
All Products
Recombinant Cynomolgus CSF1R (C-6His) [orb2994843]Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 56.1 KDa. Observed: 80-120 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg- Recombinant Cynomolgus B2M (C-Fc) [orb2994844]
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 38.8 KDa. Observed: 40 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Recombinant Human FLRT3 (C-6His) [orb2994845]
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 57.6 KDa. Observed: 60-110 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Recombinant Human CRELD2 (C-6His) [orb2994846]
Greater than 90% as determined by reducing SDS-PAGE.
Predicted: 33.4 KDa. Observed: 32-45 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Recombinant Human CDH3 (C-6His) [orb2994847]
Greater than 90% as determined by reducing SDS-PAGE.
Predicted: 70.4 KDa. Observed: 88-110 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Recombinant Human B3GNT1 (C-6His) [orb2994848]
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 43.4 KDa. Observed: 45-55 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Recombinant Rhesus Macaque CD27 (C-Fc) [orb2994849]
Greater than 90% as determined by reducing SDS-PAGE.
Predicted: 46.5 KDa. Observed: 60-90 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Recombinant Cynomolgus B2M (C-6His) [orb2994850]
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 12.5 KDa. Observed: 14 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Recombinant Cynomolgus B7-H3 (C-Fc) [orb2994851]
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 74 KDa. Observed: 100-130 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Recombinant Cynomolgus CTLA-4 (C-6His) [orb2994852]
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 14.1 KDa. Observed: 17-25 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg